<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Unit 2 Discussion Board by Rachel Westmoreland</title>
      <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680</link>
      <description>ANS</description>
      <language>en-us</language>
      <pubDate>2022-06-17 19:56:39 UTC</pubDate>
      <lastBuildDate>2025-10-01 19:34:26 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url>https://padlet.net/icons/png/1f48a.png</url>
      </image>
      <item>
         <title>Neurotransmitters: </title>
         <author>rachelwestmoreland</author>
         <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224258433</link>
         <description><![CDATA[<div>1. Acetylcholine (ACH)<br>2. Norepinephrine (NE)<br>3. Epinephrine (EPI)<br>4. Dopamine (DA)</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-06-17 20:01:44 UTC</pubDate>
         <guid>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224258433</guid>
      </item>
      <item>
         <title>Neurotransmitters:</title>
         <author>rachelwestmoreland</author>
         <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224258707</link>
         <description><![CDATA[<div>Acetylcholine (ACH)</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-06-17 20:02:45 UTC</pubDate>
         <guid>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224258707</guid>
      </item>
      <item>
         <title>Location Where NT is Released:</title>
         <author>rachelwestmoreland</author>
         <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224259033</link>
         <description><![CDATA[<div>At ganglia and post-ganglionic nerve endings </div>]]></description>
         <enclosure url="" />
         <pubDate>2022-06-17 20:03:47 UTC</pubDate>
         <guid>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224259033</guid>
      </item>
      <item>
         <title>Receptors &amp; Locations of Receptors</title>
         <author>rachelwestmoreland</author>
         <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224259732</link>
         <description><![CDATA[<div>1. Muscarinic- located on cardiac and smooth muscle and glands.<br>2. Nicotinic 1 (Nn)- located at ganglia of parasympathetic nerves and sympathetic nerves.<br>3. Nicotinic 2 (Nm)- located at neuromuscular junction of skeletal muscle.</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-06-17 20:06:10 UTC</pubDate>
         <guid>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224259732</guid>
      </item>
      <item>
         <title>Organ Responses</title>
         <author>rachelwestmoreland</author>
         <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224260904</link>
         <description><![CDATA[<div>- Heart: decreased heart rate and AV conduction, slight decrease in contractility<br>- Intestine: GI motility, and secretions increase<br>- Pupil of Eye: constriction (miosis)<br>- Respiratory Passages: bronchoconstriction<br>- Urinary Bladder: contraction<br>- Urinary Sphincter: relaxation</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-06-17 20:09:54 UTC</pubDate>
         <guid>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224260904</guid>
      </item>
      <item>
         <title>Drug Classifications + which receptors and actions</title>
         <author>rachelwestmoreland</author>
         <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224261239</link>
         <description><![CDATA[<div>Cholinergics/Parasympathomimetics:<br>- Direct-Acting Cholinergic Agonists: muscarinic receptors, mimics ACH.<br>- Indirect-Acting Cholinergic Agonists: nicotinic 2 (Nm) receptors, inhibit acetylcholinesterase.<br>Anticholinergics/Parasympatholytics: cholinergic receptors, blocking drug/competitive antagonism</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-06-17 20:10:49 UTC</pubDate>
         <guid>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224261239</guid>
      </item>
      <item>
         <title>Specific Drugs For Each Classification</title>
         <author>rachelwestmoreland</author>
         <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224267570</link>
         <description><![CDATA[<div>Cholinergics/Parasympathomimetics:<br>Direct-Acting Cholinergic Agonists-<br>- acetylcholine<br>- pilocarpine (Pilocar ®)<br>-bethanechol (Urecholine ®)<br>Indirect-Acting Cholinergic Agonists:<br>- neostigmine (Prostigmin ®)<br>Anticholinergics/Parasympatholytics<br>- atropine<br>-dicyclomine (Bentyl ®)<br>- ipratropium bromide (Atrovent ®)</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-06-17 20:29:01 UTC</pubDate>
         <guid>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224267570</guid>
      </item>
      <item>
         <title>Location Where NT is Released:</title>
         <author>rachelwestmoreland</author>
         <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224267814</link>
         <description><![CDATA[<div>1. Acetylcholine (ACH): at ganglia from presynaptic nerve endings<br>2. Norepinephrine (NE): at postsynaptic nerve endings&nbsp;<br>3. Epinephrine (EPI): released by adrenal medulla<br>4. Dopamine (DA): released from brain</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-06-17 20:29:38 UTC</pubDate>
         <guid>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224267814</guid>
      </item>
      <item>
         <title>Receptors &amp; Locations of Receptors </title>
         <author>rachelwestmoreland</author>
         <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224270031</link>
         <description><![CDATA[<div>1. Alpha 1: glands, smooth muscle, eyes, most arteries and veins.<br>2. Alpha 2: adrenergic nerve endings&nbsp;<br>3. Beta 1: heart<br>4. Beta 2: smooth muscle, lungs, uterus, skeletal muscle arteries, coronary arteries </div>]]></description>
         <enclosure url="" />
         <pubDate>2022-06-17 20:35:35 UTC</pubDate>
         <guid>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224270031</guid>
      </item>
      <item>
         <title>Organ Responses</title>
         <author>rachelwestmoreland</author>
         <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224273344</link>
         <description><![CDATA[<div>- Adrenal Medulla: release of NE<br>- Arteries: vasoconstriction (except coronary arteries and arteries to skeletal muscle, which are dilated)<br>- Heart: increased HR, AV conduction, and contractility&nbsp;<br>- Intestines: decreased GI motility and secretions<br>- Pupil of Eye: dilation (mydriasis)<br>- Respiratory Passages: bronchodilation<br>- Urinary Bladder: relaxation<br>- Urinary Sphincter: contraction </div>]]></description>
         <enclosure url="" />
         <pubDate>2022-06-17 20:43:32 UTC</pubDate>
         <guid>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224273344</guid>
      </item>
      <item>
         <title>Drug Classifications + which receptors and actions:</title>
         <author>rachelwestmoreland</author>
         <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224273464</link>
         <description><![CDATA[<div>- Alpha 1 Adrenergic Agonists: alpha 1 receptor, contraction of smooth muscle blood vessels constrict, increased BP, vasoconstriction of nasal passages.<br>- Adrenergic Agonists: alpha and beta receptors, vasoconstriction, increased BP.<br>- Alpha 1 Adrenergic Blocking: alpha 1 receptors blocked, relaxation of smooth muscle, vasodilation, decreased BP.<br>Beta Adrenergic Agonists-<br>- Beta 1 Adrenergic Agonists: low dose- dopaminergic receptors in kidneys, vasodilation and increased renal blood flow. moderate dose- beta 1 receptors in heart, increased force of contraction and cardiac output. high dose- alpha 1 receptors, vasoconstriction, increased BP.<br>- Beta 2 Adrenergic Agonists: beta 2 receptors, relaxation of smooth muscle of lungs causing bronchodilation, relaxation of smooth muscle of uterus.<br>Beta Adrenergic Blockers-<br>- Selective Beta 1 Blockers: beta 1 receptor blocked, decreased force of contraction, cardiac output, HR, conduction, and BP.<br>- Non-Selective Beta Blockers: beta 1 and beta 2 receptors blocked, decreased force of contraction, cardiac output, HR, conduction, and BP.</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-06-17 20:43:52 UTC</pubDate>
         <guid>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224273464</guid>
      </item>
      <item>
         <title>Specific Drugs For Each Classification:</title>
         <author>rachelwestmoreland</author>
         <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224283513</link>
         <description><![CDATA[<div>Alpha 1 Adrenergic Agonists-<br>- ephedrine<br>- phenylephrine (Neo-Synephrine ®)<br>Adrenergic Agonists-<br>- epinephrine (Adrenaline ®)<br>Alpha 1 Adrenergic Blockers-<br>- prazosin (Minipress ®)<br>- terazosin (Hytrin ®)<br>- doxazosin (Cardura ®)<br>Beta 1 Adrenergic Agonists-<br>- dobutamine (Dobutamine ®)<br>Beta 2 Adrenergic Agonists-<br>- albuterol (Proventil ®, Ventolin ®)<br>- terbutaline (Bretnine ®)<br>- formoterol (Foradil ®)<br>- salmeterol (Servant ®)<br>Selective Beta 1 Blockers-<br>- atenolol (Tenormin ®)<br>- metoprolol (Lopressor ®)<br>Non-Selective Beta Blockers-&nbsp;<br>- nadolol (Corgard ®)<br>- propanolol (Inderal ®)<br>- timolol (Blocadren ®)</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-06-17 21:13:37 UTC</pubDate>
         <guid>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224283513</guid>
      </item>
      <item>
         <title></title>
         <author>rachelwestmoreland</author>
         <link>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224284451</link>
         <description><![CDATA[<div>- Unit 2 ANS lecture part 1<br>- Unit 2 ANS lecture part 2&nbsp;<br>- Pharmacology Textbook "Pharmacology: An Introduction With Additional Material" -Hitner Chapters 5-7</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-06-17 21:16:29 UTC</pubDate>
         <guid>https://padlet.com/rachelwestmoreland/9eg1nbzyudd3k680/wish/2224284451</guid>
      </item>
   </channel>
</rss>
